Ronald Witteles
@Ron_Witteles
Followers
5K
Following
5K
Statuses
2K
Stanford IM residency program director, Professor of Medicine, Cardiologist, Specialist in Amyloidosis, Sarcoidosis, Cardio-Oncology, and Advanced heart failure
Joined October 2016
RT @StanfordMedRes: R2s David Mui and Chris Babu excelled at the #SGIM Regional Meeting last weekend! David scored the top for his Innovati…
0
1
0
RT @AGangavelli: 🎧 Check out our new @CardioNerds ep where I get to chat about the Nex-Z trial with amyloid expert @Ron_Witteles and @Jenna…
0
6
0
RT @StanfordMedRes: And with the conclusion of Second Look, the 2024-2025 Stanford Internal Medicine Residency interview season is over! Th…
0
3
0
RT @StanfordMedRes: Last week, the #ClinicalResearch Merit pathway group met and hosted a career panel of faculty members, which included s…
0
2
0
RT @StanfordMedRes: Who doesn’t love a fun winter celebration? ❄️☃️🩵 Last Friday, our faculty, program leadership, and residents came toge…
0
4
0
RT @StanfordMedRes: Congrats to the following residents who were recognized for their outstanding work and character in internal medicine a…
0
3
0
RT @eozdalga: Special thank you to @ChungLorinda for leading a great @StanfordMed25 session today on the exam for scleroderma. Very special…
0
6
0
RT @StanfordDeptMed: #StanDOM researchers @Ron_Witteles & Michaela Liedtke helped develop an @US_FDA-approved drug for ATTR-CM. A new lifel…
0
1
0
RT @vickyavocado: Had so much fun chatting about my Nipah virus research for the latest news letter from Stanford Center for Innovation in…
0
3
0
RT @MMoscvin: Ellen Zhang, our PGY2 @StanfordMedRes presenting data on pomalidomide in HHT at #ASH24. Our rising star in hematology ⭐️ @Ron…
0
4
0
RT @ACCinTouch: Valentin Fuster CV Symposium: Starting Day 2️⃣ with a deep dive into Myocardial Disease and Heart Failure, chaired by Dr. @…
0
3
0
RT @PeerView: Ready to TTRransform your understanding of #ATTR #amyloidosis? Explore new treatment strategies and improve your #cardiology…
0
2
0
RT @CardiBeatMD: Match Day 2019 vs Match Day 2024. I remember being lost for words when I matched into Stanford for Internal Medicine as a…
0
2
0
RT @StanfordMedRes: We are so proud of our current residents and alumni who matched at various fellowship programs across the country! Cong…
0
4
0
RT @StanfordChiefs: Scenes from our recent procedural simulation for arterial lines! Grateful to our amazing PCCM fellows for their teachin…
0
6
0
Excited to see the second ever drug approval for #ATTR cardiomyopathy. Another triumph for science 🧪 and great news for patients. Congratulations to all who have been involved in this journey! #ATTRUBY @BridgeBioPharma @MarthaGrogan1 @KMAlexanderMD @TheMahaf @Paul_P_Cheng @MathewMaurer @maz_hanna @MasriAhmadMD @BrettSperryMD @sarahcud @MargotDavisMD @RajeevCMohan @philimd @frederickruberg @dr_pavia @DorbalaSharmila @HFpEF
We are excited to announce that the U.S. FDA approved our orally-administered near-complete (≥90%) stabilizer of TTR for the treatment of adult patients with transthyretin cardiac amyloidosis (ATTR-CM). We are proud of the opportunity to serve patients within this community. Learn more:
1
14
61
RT @PeerView: Join us in TTRansforming the TTReatment of #ATTR #amyloidosis! Discover the latest in pathophysiology, diagnosis, & emerging…
0
3
0
RT @CircHF: The Great Masquerader – Diagnosing Cardiac Sarcoidosis in the Era of Advanced Cardiac Imaging @anguyen4194 @Ron_Witteles #AHAJo…
0
2
0
@KMAlexanderMD @Paul_P_Cheng @RonglihL @MarthaGrogan1 @MathewMaurer @BrettSperryMD @maz_hanna @RajeevCMohan @JLRosenthal @MargotDavisMD @vsanchorawala @awechalekar @HishamAhamed3 @MasriAhmadMD @ISA_Amyloidosis @Richardkcheng2 @JigPatelMDPhD @frederickruberg @HFpEF @EldrinL @philimd @i_lousada @DorbalaSharmila @Amyloidosis_ARC @Amyloidosisfdn
0
0
10